Quell Therapeutics Limited

AstraZeneca PLC has an ambitious goal to move from the number four cancer drug company in the world toward the top ranking and is relying on a diverse pipeline to continue the company’s impressive gr

The UK biotech sector endured a tough year in 2023, suffering a 9% decline in equity funding compared with the year before, shrinking to £1.8bn ($2.29bn). That represented a second year of decline fro

AstraZeneca has been on a sector-beating growth streak since 2018, but this could tail off in the coming years as its biggest earning therapies mature. The company believes it can sustain this perfor

The pharma, biotech and allied industries came together in London on 16 November to celebrate a year of exceptional achievement at the 19th Annual Scrip Awards. It was an occasion to applaud a wide sp